Cargando…
The Involvement of Hypoxia in the Response of Neuroblastoma Cells to the Exposure of Atorvastatin
Cancer is a set of complex diseases, being one of the leading causes of death worldwide. Despite a lot of research on the molecular pathways and effective treatments, there are still huge gaps. Indeed, the development of new anti-cancer drugs is a complex process. To face this problem, drug repurpos...
Autores principales: | Correia, Ana Salomé, Marques, Lara, Vale, Nuno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137104/ https://www.ncbi.nlm.nih.gov/pubmed/37185742 http://dx.doi.org/10.3390/cimb45040218 |
Ejemplares similares
-
Atorvastatin and Nitrofurantoin Repurposed in the Context of Breast Cancer and Neuroblastoma Cells
por: Moura, Catarina, et al.
Publicado: (2023) -
Exploring the Role of Drug Repurposing in Bridging the Hypoxia–Depression Connection
por: Correia, Ana Salomé, et al.
Publicado: (2023) -
The Effect of the Stress Induced by Hydrogen Peroxide and Corticosterone on Tryptophan Metabolism, Using Human Neuroblastoma Cell Line (SH-SY5Y)
por: Correia, Ana Salomé, et al.
Publicado: (2023) -
Oxidative Stress in Depression: The Link with the Stress Response, Neuroinflammation, Serotonin, Neurogenesis and Synaptic Plasticity
por: Correia, Ana Salomé, et al.
Publicado: (2023) -
Repurposed Edaravone, Metformin, and Perampanel as a Potential Treatment for Hypoxia–Ischemia Encephalopathy: An In Vitro Study
por: Silva, Daniela, et al.
Publicado: (2022)